News Conference News VIVA 2018 Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention L.A. McKeown November 09, 2018
News Conference News VIVA 2017 Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients L.A. McKeown September 11, 2017
News Conference News VIVA 2016 Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear L.A. McKeown September 21, 2016